Invesco Analysts Lift Targets as Earnings Loom
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Invesco arrives at its July 28 Q2 print with a wave of analyst upgrades at its back and options traders noticeably more hedged than they were just a week ago.
The analyst story is unusually one-directional ahead of this release. Across five separate actions in the past two weeks, every firm that moved a target moved it higher — RBC Capital lifted to $33 (from $31) on July 23, Barclays raised to $31 from $26, Morgan Stanley nudged to $30 from $29, and Evercore ISI moved to $32. None of these moves came with a rating upgrade; all four firms held their existing stances. That combination — rising targets, unchanged ratings — reflects a Street that acknowledges the stock's 11% rally over the past month but is not yet ready to call it a full re-rating. The consensus mean target of $31.58 sits only modestly above the current $29.93, leaving limited implied upside even after the target revisions.
Options traders have turned more defensive since the last article on this name. The put/call ratio has climbed to 0.233, roughly 1.5 standard deviations above its 20-day average of 0.178 — the highest reading in several weeks. That shift happened quickly: the PCR was below 0.15 for most of the first two weeks of July before jumping sharply around July 20. The move is notable, though context matters — the 52-week high is 0.40, so this is elevated caution, not alarm. Short interest tells a calmer story than it did ten days ago. The position has stabilised near 4.2% of the free float after its mid-July spike, with only fractional daily changes since July 10. Cost to borrow remains negligible at 0.47%, and borrow availability is extraordinarily loose at over 4,400% — meaning new shorts face no mechanical friction whatsoever if they choose to press the trade.
The bull case rests on momentum: the EPS momentum factor ranks in the 91st percentile over 30 days and the 86th over 90 days, and the stock has outrun most asset-management peers year-to-date despite trailing European names like DWS and Amundi. Bears point to the valuation ceiling — price-to-book below 1 and a PE near 9.9x reflect persistent fee-pressure concerns and questions about Invesco's active-versus-passive mix — and to the fact that the Street's most bullish firm, RBC, is still only at $33 on a stock that has already run to $30.
The July 28 print will test whether Q2 AUM flows and fee-rate trends justify the multiple expansion the stock has already priced in, or whether the target-raising cycle finds its ceiling at a number that leaves bulls with little margin for disappointment.
Stocks in this article
See the live data behind this article on ORTEX.
Open IVZ on ORTEX →How this article was generated
- Generated
- 25 Jul 2026, 04:17
- Data as of
- 25 Jul 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.